Logo image of GNS

GENIUS GROUP LTD (GNS) Stock Fundamental Analysis

NYSEARCA:GNS - NYSE Arca - SGXZ81555062 - Common Stock - Currency: USD

0.2491  +0 (+0.24%)

After market: 0.2723 +0.02 (+9.31%)

Fundamental Rating

4

Overall GNS gets a fundamental rating of 4 out of 10. We evaluated GNS against 71 industry peers in the Diversified Consumer Services industry. While GNS seems to be doing ok healthwise, there are quite some concerns on its profitability. GNS is valued quite expensive, but it does show an excellent growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year GNS has reported negative net income.
GNS had negative earnings in each of the past 5 years.
GNS had a negative operating cash flow in each of the past 5 years.
GNS Yearly Net Income VS EBIT VS OCF VS FCFGNS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 -10M -20M -30M -40M -50M

1.2 Ratios

With a Return On Assets value of -7.22%, GNS perfoms like the industry average, outperforming 50.70% of the companies in the same industry.
GNS's Return On Equity of -11.55% is in line compared to the rest of the industry. GNS outperforms 52.11% of its industry peers.
Industry RankSector Rank
ROA -7.22%
ROE -11.55%
ROIC N/A
ROA(3y)-32.92%
ROA(5y)-24.83%
ROE(3y)-312.72%
ROE(5y)-200.62%
ROIC(3y)N/A
ROIC(5y)N/A
GNS Yearly ROA, ROE, ROICGNS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 -200 -400 -600

1.3 Margins

GNS has a Gross Margin of 51.76%. This is in the better half of the industry: GNS outperforms 61.97% of its industry peers.
In the last couple of years the Gross Margin of GNS has grown nicely.
GNS does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 51.76%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.13%
GM growth 5YN/A
GNS Yearly Profit, Operating, Gross MarginsGNS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 0 -100 -200 -300

More info and screens

4

2. Health

2.1 Basic Checks

GNS does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for GNS has been increased compared to 1 year ago.
The debt/assets ratio for GNS has been reduced compared to a year ago.
GNS Yearly Shares OutstandingGNS Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 5M 10M 15M 20M
GNS Yearly Total Debt VS Total AssetsGNS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 20M 40M 60M 80M

2.2 Solvency

GNS has an Altman-Z score of -1.21. This is a bad value and indicates that GNS is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -1.21, GNS is doing worse than 66.20% of the companies in the same industry.
A Debt/Equity ratio of 0.03 indicates that GNS is not too dependend on debt financing.
GNS's Debt to Equity ratio of 0.03 is fine compared to the rest of the industry. GNS outperforms 66.20% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Altman-Z -1.21
ROIC/WACCN/A
WACC9.5%
GNS Yearly LT Debt VS Equity VS FCFGNS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 0 5M -5M 10M -10M

2.3 Liquidity

GNS has a Current Ratio of 2.52. This indicates that GNS is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 2.52, GNS is in the better half of the industry, outperforming 78.87% of the companies in the same industry.
A Quick Ratio of 2.48 indicates that GNS has no problem at all paying its short term obligations.
With a decent Quick ratio value of 2.48, GNS is doing good in the industry, outperforming 78.87% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.52
Quick Ratio 2.48
GNS Yearly Current Assets VS Current LiabilitesGNS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 5M 10M 15M 20M

More info and screens

8

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 95.87% over the past year.
The Revenue has grown by 26.76% in the past year. This is a very strong growth!
The Revenue has been growing by 44.56% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)95.87%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)26.76%
Revenue growth 3Y44.56%
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

The Earnings Per Share is expected to grow by 35.28% on average over the next years. This is a very strong growth
GNS is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 83.01% yearly.
EPS Next Y69.76%
EPS Next 2Y39.97%
EPS Next 3Y35.28%
EPS Next 5YN/A
Revenue Next Year-37.97%
Revenue Next 2Y-4.36%
Revenue Next 3Y83.01%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
GNS Yearly Revenue VS EstimatesGNS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 50M 100M 150M
GNS Yearly EPS VS EstimatesGNS Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 0 1 -1 -2

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

GNS reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for GNS. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
GNS Price Earnings VS Forward Price EarningsGNS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
GNS Per share dataGNS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5

4.3 Compensation for Growth

A more expensive valuation may be justified as GNS's earnings are expected to grow with 35.28% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y39.97%
EPS Next 3Y35.28%

More info and screens

0

5. Dividend

5.1 Amount

GNS does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

GENIUS GROUP LTD

NYSEARCA:GNS (4/17/2025, 8:25:13 PM)

After market: 0.2723 +0.02 (+9.31%)

0.2491

+0 (+0.24%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryDiversified Consumer Services
Earnings (Last)05-16 2024-05-16/amc
Earnings (Next)N/A N/A
Inst Owners0.3%
Inst Owner Change0%
Ins Owners1.26%
Ins Owner ChangeN/A
Market Cap17.08M
AnalystsN/A
Price Target33.15 (13207.91%)
Short Float %5.8%
Short Ratio1.01
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-456.25%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-44.49%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.74
P/FCF N/A
P/OCF N/A
P/B 0.35
P/tB 0.74
EV/EBITDA N/A
EPS(TTM)-0.91
EYN/A
EPS(NY)-0.12
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0.34
BVpS0.71
TBVpS0.34
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -7.22%
ROE -11.55%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 51.76%
FCFM N/A
ROA(3y)-32.92%
ROA(5y)-24.83%
ROE(3y)-312.72%
ROE(5y)-200.62%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.13%
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0.29
Health
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.52
Quick Ratio 2.48
Altman-Z -1.21
F-ScoreN/A
WACC9.5%
ROIC/WACCN/A
Cap/Depr(3y)42.14%
Cap/Depr(5y)50.64%
Cap/Sales(3y)6.65%
Cap/Sales(5y)7.88%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)95.87%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next Y69.76%
EPS Next 2Y39.97%
EPS Next 3Y35.28%
EPS Next 5YN/A
Revenue 1Y (TTM)26.76%
Revenue growth 3Y44.56%
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next Year-37.97%
Revenue Next 2Y-4.36%
Revenue Next 3Y83.01%
Revenue Next 5YN/A
EBIT growth 1Y-53.12%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year36.47%
EBIT Next 3Y39.32%
EBIT Next 5YN/A
FCF growth 1Y-36.87%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-50.66%
OCF growth 3YN/A
OCF growth 5YN/A